Immuneering (IMRX) Receivables - Net (2020 - 2023)
Historic Receivables - Net for Immuneering (IMRX) over the last 4 years, with Q1 2023 value amounting to $1046.0.
- Immuneering's Receivables - Net fell 9962.59% to $1046.0 in Q1 2023 from the same period last year, while for Mar 2023 it was $1046.0, marking a year-over-year decrease of 9962.59%. This contributed to the annual value of $12417.0 for FY2022, which is 9495.33% down from last year.
- Latest data reveals that Immuneering reported Receivables - Net of $1046.0 as of Q1 2023, which was down 9962.59% from $12417.0 recorded in Q4 2022.
- In the past 5 years, Immuneering's Receivables - Net ranged from a high of $500110.0 in Q4 2020 and a low of $1046.0 during Q1 2023
- Moreover, its 4-year median value for Receivables - Net was $246040.0 (2021), whereas its average is $250479.1.
- As far as peak fluctuations go, Immuneering's Receivables - Net tumbled by 5080.28% in 2021, and later plummeted by 9962.59% in 2023.
- Over the past 4 years, Immuneering's Receivables - Net (Quarter) stood at $500110.0 in 2020, then plummeted by 50.8% to $246040.0 in 2021, then tumbled by 94.95% to $12417.0 in 2022, then tumbled by 91.58% to $1046.0 in 2023.
- Its Receivables - Net was $1046.0 in Q1 2023, compared to $12417.0 in Q4 2022 and $70180.0 in Q3 2022.